Q1FY25 Review: Nifty 50 delivers first single-digit EBITDA growth in four years; Auto, banks lead the pack

  • Q1FY25 Review: The overall growth in the first quarter of current fiscal was primarily propelled by domestic cyclicals. The notable contributions were witnessed from the healthcare, real estate, capital goods, and metals sectors

Nikita Prasad
Published16 Aug 2024, 08:37 PM IST
Trade Now
Q1FY25 Review: The overall growth in the first quarter of the current fiscal was primarily propelled by domestic cyclicals
Q1FY25 Review: The overall growth in the first quarter of the current fiscal was primarily propelled by domestic cyclicals

Q1FY25 Review: Nifty 50 delivered a four per cent year-on-year (YoY) growth in the April-June quarter of fiscal 2024-25 (Q1FY25), slightly higher than most D-Street estimates. At five per cent, the NSE benchmark reported the first quarter of a single-digit EBITDA growth in four years in the quarter under review. The last time when the benchmark posted a single-digit EBITDA growth was in September 2020.

According to domestic brokerage Motilal Oswal Financial Services, the net profit of four per cent is the lowest since the COVID-19 pandemic quarter (June 2020). The overall growth in the first quarter of the current fiscal was primarily propelled by domestic cyclicals. The notable contributions were witnessed from the healthcare, real estate, capital goods, and metals sectors.

The aggregate performance was hit by a drag from oil marketing companies (OMCs).  Five Nifty companies – HDFC Bank, Tata Motors, ICICI Bank, Maruti Suzuki, and TCS – contributed 127 per cent of the incremental YoY accretion in earnings. Conversely, BPCL, JSW Steel, ONGC, Reliance Industries, and Grasim Industries contributed adversely to the Nifty earnings.

Also Read: Q1FY25 review: Nifty PAT growth lowest since June 2020, says Motilal Oswal, lists top earnings upgrades and downgrades

Auto, banks lead the pack in Q1FY25

According to domestic brokerage Elara Securities (India) Pvt Ltd, the auto sector surpassed expectations, with most companies, except for commercial vehicles and tire plays, seeing a decent YoY growth. 

The banking sector modestly exceeded the brokerage's tempered expectations despite facing headwinds. However, challenges persist with sluggish deposit momentum exerting pressure on net interest margins (NIMs) and signs of moderation in the unsecured loan segment.

FMCG, Pharma pack rise to compete

The long-anticipated rural consumption recovery shows promising signs for the fast-moving consumer goods (FMCG) sector. While FY24 earnings growth was driven by price increases, volume-led growth is expected to be the norm going forward. Although rural growth still lags urban on two-year CAGR basis, it has picked up YoY while urban growth has slowed.

For Pharma, earnings growth of ~28 per cent YoY marginally exceeded the brokerage's projections, but performance varied across the sector. The US generics business remains the primary growth driver, even as CDMO companies face persistent challenges. Major hospital chains showed early signs of growth deceleration and margin pressure.

Also Read: IT Earnings Review: MOFSL likes HCL Tech and LTI Mindtree among largecaps, Persistent Systems in midcaps

Energy / Metal / Cement sectors face margin strain

Commodity-oriented sectors experienced a modest topline growth but saw earnings decline by ~27 per cent owing to margin pressure. The energy pack registered a 30 per cemt earnings drop, attributed to lower gross refining margin, decreased retail diesel margin for OMCs, and weaker performance in Reliance Industries’ oil-to-chemicals segment. Steel and cement companies were hit by weak hot rolled coil prices and cement prices respectively.

Valuations

According to Motilal Oswal, the Nifty EPS estimate for FY25 was cut by 1.7 per cent to 1,115, largely owing to Reliance Industries, Oil and Natural Gas Corp (ONGC), and Bharat Petroleum Corp Ltd (BPCL). 

‘’FY26E EPS was also trimmed by one per cent to 1,316 (from 1,330) as upgrades in Infosys, Coal India, Tata Motors, and Maruti Suzuki were offset by downgrades in ONGC, Axis Bank, HDFC Bank, ICICI Bank, and IndusInd Bank. Positive on auto, capital goods, FMCG, energy, pharma, real estate,'' said the brokerage.

Also Read: Bata India Q1 Results: Net profit rises 63% to 174 crore, revenue down 1.5% YoY; dividend declared

According to Elara Capital, valuations remain the focal point, with indices trading at premium levels, sustained by strong earnings delivery. While the banks do face pressure, this is largely priced in. The outlook for capital goods and infrastructure remains positive as election-related softness subsides. 

‘’Above-average monsoons align with IMD forecasts, potentially boosting rural consumption and benefiting FMCG and small-ticket white goods sectors. We maintain our positive stance on Autos, Capital Goods, FMCG, Energy, Pharma, and Real Estate. Our outlook is negative for Cement, Chemicals, and Metals, while remaining neutral for other sectors,'' said Elara Capital.
 

Disclaimer: The views and recommendations provided in this analysis are those of individual analysts or broking companies, not Mint. We strongly advise investors to consult with certified experts before making any investment decisions, as market conditions can change rapidly and individual circumstances may vary.

 

Catch all the Business News , Market News , Breaking News Events and Latest News Updates on Live Mint. Download The Mint News App to get Daily Market Updates.

MoreLess
First Published:16 Aug 2024, 08:37 PM IST
Business NewsMarketsStock MarketsQ1FY25 Review: Nifty 50 delivers first single-digit EBITDA growth in four years; Auto, banks lead the pack

Most Active Stocks

Tata Steel share price

155.25
03:58 PM | 16 OCT 2024
-0.4 (-0.26%)

Tata Power share price

460.35
03:58 PM | 16 OCT 2024
-3.15 (-0.68%)

Bharat Petroleum Corporation share price

350.85
03:57 PM | 16 OCT 2024
1.65 (0.47%)

Bharat Electronics share price

285.65
03:49 PM | 16 OCT 2024
-3.15 (-1.09%)
More Active Stocks

Market Snapshot

  • Top Gainers
  • Top Losers
  • 52 Week High

Coforge share price

7,120.75
10:51 AM | 7 OCT 2024
-2.4 (-0.03%)

Vijaya Diagnostic Centre share price

984.80
10:51 AM | 7 OCT 2024
-4.15 (-0.42%)

Dr. Lal Pathlabs share price

3,408.00
10:50 AM | 7 OCT 2024
-86.25 (-2.47%)
More from 52 Week High

Bombay Burmah Trading Corporation share price

2,519.95
10:51 AM | 7 OCT 2024
-245.3 (-8.87%)

Jubilant Ingrevia share price

728.55
10:51 AM | 7 OCT 2024
-65.7 (-8.27%)

Triveni Engineering & Indus share price

426.65
10:51 AM | 7 OCT 2024
-35.75 (-7.73%)

Vodafone Idea share price

9.08
10:51 AM | 7 OCT 2024
-0.72 (-7.35%)
More from Top Losers

Astrazeneca Pharma India share price

7,832.35
10:51 AM | 7 OCT 2024
399.85 (5.38%)

Finolex Industries share price

280.85
10:51 AM | 7 OCT 2024
9.2 (3.39%)

Macrotech Developers share price

1,206.20
10:51 AM | 7 OCT 2024
34.35 (2.93%)

JK Lakshmi Cement share price

797.60
10:51 AM | 7 OCT 2024
17.2 (2.2%)
More from Top Gainers

    Recommended For You

      More Recommendations

      Gold Prices

      • 24K
      • 22K
      Bangalore
      77,405.00-220.00
      Chennai
      77,411.00-220.00
      Delhi
      77,563.00-220.00
      Kolkata
      77,415.00-220.00

      Fuel Price

      • Petrol
      • Diesel
      Bangalore
      102.86/L0.00
      Chennai
      100.75/L0.00
      Kolkata
      104.95/L0.00
      New Delhi
      94.72/L0.00

      Popular in Markets

        HomeMarketsPremiumInstant LoanMint Shorts